Methylphenidate Treatment for Cocaine Abuse and ADHD - 1

Completed · Phase 1 · Has a placebo group

Conditions studied: Attention Deficit Disorder With Hyperactivity, Cocaine-Related Disorders

In brief

Many cocaine dependent individuals are also diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Methylphenidate (Ritalin) is currently approved to treat individuals diagnosed with ADHD. The purpose of this study is to determine the effectiveness of methylphenidate in treating ADHD symptoms in cocaine dependent individuals.

Key facts

Study ID

NCT00136734

Run by

New York State Psychiatric Institute

People needed

124

Starts

1998-04-01

Expected to finish

2004-03-01

Last updated by the study team

2019-04-23

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets DSM-IV criteria for cocaine dependence
• Meets DSM-IV criteria for persistent adult Attention Deficit Hyperactive Disorder

You may not qualify if…

• Meets DSM-IV criteria for current psychiatric disorders (other than ADHD or substance abuse) that requires a psychiatric intervention
• Physiologically dependent on sedatives or alcohol, to the extent that medical attention is required during periods of abstinence or significant reduction in the amount of use
• Exhibits suicidal or homicidal behavior within the two years prior to enrollment
• Currently taking prescription psychotropic medication
• Unstable medical condition (e.g., uncontrolled diabetes) that would make participation in the study hazardous
• Known sensitivity to methylphenidate
• Pregnant or breastfeeding

Where it is running

• Research Foundation for Mental Hygiene, Inc. — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.